Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Islet Graft Function
NCT00853944Phase 3Terminated
- Sponsor
- University of British Columbia
- Start
- Jul 2009
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 1 diabetes mellitus (T1D), sponsored by University of British Columbia. Started Jul 2009; status: terminated.
02
Drugs
sitagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00853944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853944.